PTEN and PTEN hamartoma tumor syndrome: Furthermore, the molecular investigations carried out on tissues of real patients taken from this case series provide some insights into the mechanisms implicated in the development of clinical manifestations of PHTS, offering additional support to the evidence that PTEN does not behave like a classic tumor-suppressor gene and highlighting the importance of the individual genetic background in the expressiveness of this pathology.